128 related articles for article (PubMed ID: 1868036)
1. Localization of the HST/FGFK gene with regard to 11q13 chromosomal breakpoint and fragile site.
Hagemeijer A; Lafage M; Mattei MG; Simonetti J; Smit E; de Lapeyriere O; Birnbaum D
Genes Chromosomes Cancer; 1991 May; 3(3):210-4. PubMed ID: 1868036
[TBL] [Abstract][Full Text] [Related]
2. Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC.
Galiègue-Zouitina S; Collyn-d'Hooghe M; Denis C; Mainardi A; Hildebrand MP; Tilly H; Bastard C; Kerckaert JP
Genes Chromosomes Cancer; 1994 Dec; 11(4):246-55. PubMed ID: 7533528
[TBL] [Abstract][Full Text] [Related]
3. Translocation breakpoint in t(11;14) in B-cell leukemia is not at the rare fragile site at 11q13.3.
Puspurs AH; Baker E; Callen DF; Fratini A; Sutherland GR
Cancer Genet Cytogenet; 1988 Mar; 31(1):25-30. PubMed ID: 2830961
[TBL] [Abstract][Full Text] [Related]
4. Mapping FRA11A, a folate-sensitive fragile site in human chromosome band 11q13.3.
Perucca-Lostanlen D; Hecht BK; Courseaux A; Grosgeorge J; Hecht F; Gaudray P
Cytogenet Cell Genet; 1997; 79(1-2):88-91. PubMed ID: 9533019
[TBL] [Abstract][Full Text] [Related]
5. The 11q13 amplicon of a mammary carcinoma cell line.
Lafage M; Nguyen C; Szepetowski P; Pébusque MJ; Simonetti J; Courtois G; Gaudray P; deLapeyriere O; Jordan B; Birnbaum D
Genes Chromosomes Cancer; 1990 Sep; 2(3):171-81. PubMed ID: 2078507
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal localization of the hst oncogene and its co-amplification with the int.2 oncogene in a human melanoma.
Adelaide J; Mattei MG; Marics I; Raybaud F; Planche J; De Lapeyriere O; Birnbaum D
Oncogene; 1988 Apr; 2(4):413-6. PubMed ID: 3283658
[TBL] [Abstract][Full Text] [Related]
7. Further localization of ETS1 indicates that the chromosomal rearrangement in Ewing sarcoma does not occur at fra(11)(q23).
Simmers RN; Sutherland GR
Hum Genet; 1988 Feb; 78(2):144-7. PubMed ID: 3422214
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;q32).
Kobayashi H; Kitano K; Saito H; Aoki K; Narita A; Terada N; Sonoyama M; Uchimaru K; Machii T; Motokura T
Cancer Genet Cytogenet; 1995 Oct; 84(1):69-72. PubMed ID: 7497446
[TBL] [Abstract][Full Text] [Related]
9. Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization.
Coignet LJ; Schuuring E; Kibbelaar RE; Raap TK; Kleiverda KK; Bertheas MF; Wiegant J; Beverstock G; Kluin PM
Blood; 1996 Feb; 87(4):1512-9. PubMed ID: 8608242
[TBL] [Abstract][Full Text] [Related]
10. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.
Ali IU; Merlo G; Callahan R; Lidereau R
Oncogene; 1989 Jan; 4(1):89-92. PubMed ID: 2915903
[TBL] [Abstract][Full Text] [Related]
11. Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia.
Kuriakose P; Perveen N; Maeda K; Wiktor A; Van Dyke DL
Cancer Genet Cytogenet; 2004 Apr; 150(2):156-8. PubMed ID: 15066324
[TBL] [Abstract][Full Text] [Related]
12. Molecular mapping of the chromosome 11 breakpoint of t(11;17)(q13;q21) in a t(11;14)(q13;q32)-positive B non-Hodgkin's lymphoma.
Wlodarska I; Schoenmakers E; Kas K; Merregaert J; Lemahieu V; Weier U; Van den Berghe H; Van de Ven WJ
Genes Chromosomes Cancer; 1993 Dec; 8(4):224-9. PubMed ID: 7512365
[TBL] [Abstract][Full Text] [Related]
13. BCL-1 participates in the 11q13 amplification found in breast cancer.
Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
[TBL] [Abstract][Full Text] [Related]
14. Cloning of the t(11;14)(q13;q32) translocation breakpoints from two human leukemia cell lines.
Meeker TC; Sellers W; Harvey R; Withers D; Carey K; Xiao H; Block AM; Dadey B; Han T
Leukemia; 1991 Sep; 5(9):733-7. PubMed ID: 1943225
[TBL] [Abstract][Full Text] [Related]
15. [Isolation of a novel candidate proto-oncogene involved in human lymphoid neoplasm].
Ohno H
Rinsho Ketsueki; 1991 Jun; 32(6):655-9. PubMed ID: 1890743
[TBL] [Abstract][Full Text] [Related]
16. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
[TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
[TBL] [Abstract][Full Text] [Related]
18. The FGF-related oncogenes hst and int.2, and the bcl.1 locus are contained within one megabase in band q13 of chromosome 11, while the fgf.5 oncogene maps to 4q21.
Nguyen C; Roux D; Mattei MG; de Lapeyriere O; Goldfarb M; Birnbaum D; Jordan BR
Oncogene; 1988 Dec; 3(6):703-8. PubMed ID: 2577873
[TBL] [Abstract][Full Text] [Related]
19. Description of a 700-kb yeast artificial chromosome contig containing the BCL1 translocation breakpoint region at 11q13.
Szepetowski P; Perucca-Lostanlen D; Grosgeorge J; LePaslier D; Brownstein BH; Carle GF; Gaudray P
Cytogenet Cell Genet; 1995; 69(1-2):101-7. PubMed ID: 7835075
[TBL] [Abstract][Full Text] [Related]
20. Fragile sites at 16q22 are not at the breakpoint of the chromosomal rearrangement in AMMoL.
Simmers RN; Sutherland GR; West A; Richards RI
Science; 1987 Apr; 236(4797):92-4. PubMed ID: 3470945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
